Strategic objectives

• To consolidate the research group once its younger members move on to more stable positions at universities and/or hospitals, positioning our group as a leader in pharmacoepidemiological research and fostering collaboration with groups within our clinical-academic community and in other fields.
• To consolidate PIELenRed in the Community of Madrid as an interdisciplinary research platform and extend collaboration to other hospitals nationwide, while maintaining its integration into the international RegiSCAR consortium.
• To expand access to additional information sources beyond BIFAP.

Research lines

• Cardiovascular and renal events and medication use.
• Severe skin reactions to medications (Type IV hypersensitivity reactions). Clinical-epidemiological study and search for susceptibility markers.
• Pharmacoepidemiological evaluation of chemoprophylaxis in gastrointestinal cancer.